The intersection of impact and health

Join Streamly for free to watch more
The intersection of impact and health

The intersection of impact and health

About the speaker
  • Lucas De Breed
    Lucas De Breed
    Director, Investments, BrightEdge at American Cancer Society
    Dr. de Breed has two decades of experience in Oncology, as a scientist, strategy consultant, VC and entrepreneur. Previously, as a Manager at Deallus, a global strategy consulting firm for large biopharma clients, he led the Oncology business unit and founded the firm’s East Coast office. As an Investment Director at INKEF Capital, a leading European VC firm, Lucas led the allocation of $120 million in US and European therapeutics start-ups, served on the respective Boards, and realized a number of exits. At INKEF, he was instrumental in setting the investment strategy, building out the investment team and in expanding assets under management to $600 million. He is also the Founder of August, developing outcomes-based financial solutions for high-cost precision medicine. Dr. de Breed holds a PhD in Molecular Oncology from University College London and an MBA from Stanford University. He has also co-authored several scientific papers. Lucas also serves on the Board of Quantum Leap Healthcare, a 501c(3)charitable organization integrating high-impact clinical research with patient care to improve and save lives.

Key takeaways